임상 시험 Nct 페이지
Clinical Trial Results:
Phase II Study with Gefitinib (sequentially) following Gemcitabine/Cisplatin as induction regimen for patients with stage IIIA N2 NSCLC.
| Summary | |
EudraCT number | 2004-001332-23 |
Trial protocol | BE |
Global completion date | 04 Nov 2005 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 29 Mar 2017 |
First version publication date | 29 Mar 2017 |
Other versions | |
Summary report(s) | 08013 short report |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.